{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:07:42Z","timestamp":1793632062607,"version":"4.5.1"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2012,10,25]],"date-time":"2012-10-25T00:00:00Z","timestamp":1351123200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0047559","type":"journal-article","created":{"date-parts":[[2012,10,25]],"date-time":"2012-10-25T17:32:01Z","timestamp":1351186321000},"page":"e47559","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1008,"title":["Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials"],"prefix":"10.1371","volume":"7","author":[{"given":"Manoj M.","family":"Lalu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauralyn","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Fergusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent W.","family":"Winston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Granton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan J.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Canadian Critical Care Trials Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,10,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00007890-197404000-00001","article-title":"Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo","volume":"17","author":"AJ Friedenstein","year":"1974","journal-title":"Transplantation"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/path.2469","article-title":"Why are MSCs therapeutic? New data: new insight","volume":"217","author":"AI Caplan","year":"2009","journal-title":"J Pathol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"S569","DOI":"10.1097\/CCM.0b013e3181f1ff1d","article-title":"Mesenchymal stem cells for acute lung injury: preclinical evidence","volume":"38","author":"MA Matthay","year":"2010","journal-title":"Crit Care Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1371\/journal.pmed.0040269","article-title":"Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1","volume":"4","author":"SH Mei","year":"2007","journal-title":"PLoS Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1164\/rccm.201001-0010OC","article-title":"Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis","volume":"182","author":"SHJ Mei","year":"2010","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-1-60761-705-1_5","article-title":"Mesenchymal stem cell therapy for cardiac repair","volume":"660","author":"AJ Boyle","year":"2010","journal-title":"Methods Mol Biol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3109\/14653249.2010.507330","article-title":"Defining the risks of mesenchymal stromal cell therapy","volume":"12","author":"DJ Prockop","year":"2010","journal-title":"Cytotherapy"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Green S, editors (2009) Cochrane Handbook for Systematic Reviews of Interventions. 5.0.2 ed.","DOI":"10.1002\/9780470712184"},{"key":"ref9","first-page":"S57","article-title":"The value of meta-analysis in rheumatology research","volume":"3 Suppl 1","author":"JP Ioannidis","year":"2004","journal-title":"Autoimmun Rev"},{"key":"ref10","unstructured":"(2005) Cochrane Handbook for Systematic Reviews of Interventions 4.2.5, The Cochrane Library. In: Higgins JPT, Green S, editors. Chichester, UK: John Wiley & Sons, Ltd."},{"key":"ref11","first-page":"552","article-title":"Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery","volume":"18","author":"S Chen","year":"2006","journal-title":"J Invasive Cardiol"},{"key":"ref12","first-page":"1443","article-title":"Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction","volume":"117","author":"SL Chen","year":"2004","journal-title":"Chin Med J (Engl)"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/j.jacc.2009.06.055","article-title":"A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction","volume":"54","author":"JM Hare","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/stem.430","article-title":"A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke","volume":"28","author":"JS Lee","year":"2010","journal-title":"Stem Cells"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/sj.clpt.6100386","article-title":"Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy","volume":"83","author":"PH Lee","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/sj.leu.2405090","article-title":"The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study","volume":"22","author":"H Ning","year":"2008","journal-title":"Leukemia"},{"key":"ref17","first-page":"107","article-title":"[A prospective, randomized, controlled trial of autologous mesenchymal stem cells transplantation for dilated cardiomyopathy]","volume":"34","author":"JA Wang","year":"2006","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"ref18","first-page":"1277","article-title":"Curative effect of autologous mesenchymal stem cell transplantation on spinal cord injury. [Chinese]","volume":"11","author":"ZW Xie","year":"2007","journal-title":"Journal of Clinical Rehabilitative Tissue Engineering Research"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.bbmt.2010.01.011","article-title":"Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning","volume":"16","author":"F Baron","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/14653240902807018","article-title":"Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults","volume":"11","author":"R Gonzalo-Daganzo","year":"2009","journal-title":"Cytotherapy"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.bbmt.2008.03.012","article-title":"Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease","volume":"15","author":"P Kebriaei","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/sj.bmt.1703650","article-title":"Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH)","volume":"30","author":"ON Koc","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"ref23","first-page":"557","article-title":"Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use","volume":"16","author":"HM Lazarus","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2005.02.001","article-title":"Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients","volume":"11","author":"HM Lazarus","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1089\/scd.2006.15.349","article-title":"Ex vivo expansion and in vivo infusion of bone marrow-derived Flk-1+CD31-CD34- mesenchymal stem cells: feasibility and safety from monkey to human","volume":"15","author":"L Liu","year":"2006","journal-title":"Stem Cells Dev"},{"key":"ref26","first-page":"467","article-title":"Autologous in vitro expanded mesenchymal stem cell therapy for human old myocardial infarction","volume":"10","author":"M Mohyeddin-Bonab","year":"2007","journal-title":"Arch Iran Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/01.tp.0000214462.63943.14","article-title":"Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease","volume":"81","author":"O Ringden","year":"2006","journal-title":"Transplantation"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11255-009-9659-1","article-title":"Effect of co-transplantation of mesenchymal stem cells and hematopoietic stem cells as compared to hematopoietic stem cell transplantation alone in renal transplantation to achieve donor hypo-responsiveness","volume":"43","author":"AV Vanikar","year":"2011","journal-title":"Int Urol Nephrol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3109\/14653240903390795","article-title":"Single intra-arterial injection of mesenchymal stromal cells for treatment of steroid-refractory acute graft-versus-host disease: a pilot study","volume":"12","author":"N Arima","year":"2010","journal-title":"Cytotherapy"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1136\/gut.2010.215152","article-title":"Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study","volume":"59","author":"M Duijvestein","year":"2010","journal-title":"Gut"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1016\/j.transproceed.2007.08.103","article-title":"Favorable response to human adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versus-host disease","volume":"39","author":"B Fang","year":"2007","journal-title":"Transplant Proc"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/brain\/awr063","article-title":"Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke","volume":"134","author":"O Honmou","year":"2011","journal-title":"Brain"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/archneurol.2010.248","article-title":"Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis","volume":"67","author":"D Karussis","year":"2010","journal-title":"Arch Neurol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"K Le Blanc","year":"2008","journal-title":"Lancet"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/ard.2009.123463","article-title":"Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study","volume":"69","author":"J Liang","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"ref36","article-title":"Allogeneic mesenchymal stem cell transplantation in seven patients with refractory inflammatory bowel disease","author":"J Liang","year":"2011","journal-title":"Gut"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1089\/scd.2009.0029","article-title":"Infusion of mesenchymal stromal cells can aid hematopoietic recovery following allogeneic hematopoietic stem cell myeloablative transplant: a pilot study","volume":"18","author":"N Meuleman","year":"2009","journal-title":"Stem Cells Dev"},{"key":"ref38","first-page":"459","article-title":"Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis","volume":"10","author":"M Mohamadnejad","year":"2007","journal-title":"Arch Iran Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1038\/sj.leu.2404833","article-title":"Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon","volume":"21","author":"O Ringden","year":"2007","journal-title":"Leukemia"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/stem.68","article-title":"Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans","volume":"27","author":"L Sun","year":"2009","journal-title":"Stem Cells"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1002\/art.27548","article-title":"Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus","volume":"62","author":"L Sun","year":"2010","journal-title":"Arthritis Rheum"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1136\/ard.2010.141804","article-title":"Efficacy of allogeneic mesenchymal stem cell transplantation in patients with drug-resistant polymyositis and dermatomyositis","volume":"70","author":"D Wang","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1038\/bmt.2010.195","article-title":"Mesenchymal stem cell as salvage treatment for refractory chronic GVHD","volume":"45","author":"JY Weng","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1755-5922.2009.00116.x","article-title":"A novel approach to transplanting bone marrow stem cells to repair human myocardial infarction: delivery via a noninfarct-relative artery","volume":"28","author":"Z Yang","year":"2010","journal-title":"Cardiovasc Ther"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1751-553X.2009.01181.x","article-title":"Cotransplantation of HLA-identical mesenchymal stem cells and hematopoietic stem cells in Chinese patients with hematologic diseases","volume":"32","author":"X Zhang","year":"2010","journal-title":"Int J Lab Hematol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/14653240701883061","article-title":"A combined procedure to deliver autologous mesenchymal stromal cells to patients with traumatic brain injury","volume":"10","author":"ZX Zhang","year":"2008","journal-title":"Cytotherapy"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1182\/blood-2003-04-1193","article-title":"Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals","volume":"102","author":"F Djouad","year":"2003","journal-title":"Blood"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nri2395","article-title":"Mesenchymal stem cells in health and disease","volume":"8","author":"A Uccelli","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/sj.bmt.1705255","article-title":"Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen","volume":"37","author":"P Frere","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1213\/ane.0b013e3181930a6e","article-title":"Noninfectious serious hazards of transfusion","volume":"108","author":"JE Hendrickson","year":"2009","journal-title":"Anesth Analg"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0301-472X(03)00110-3","article-title":"HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells","volume":"31","author":"K Le Blanc","year":"2003","journal-title":"Exp Hematol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1634\/stemcells.2005-0094","article-title":"In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability","volume":"23","author":"A Shahdadfar","year":"2005","journal-title":"Stem Cells"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ymthe.2004.02.012","article-title":"Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy","volume":"9","author":"JL Spees","year":"2004","journal-title":"Mol Ther"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbmt.2003.09.016","article-title":"The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity","volume":"10","author":"R Syme","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/sj.bmt.1705100","article-title":"Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres","volume":"36","author":"P Windrum","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/00006231-200311000-00005","article-title":"111In oxine labelled mesenchymal stem cell SPECT after intravenous administration in myocardial infarction","volume":"24","author":"BB Chin","year":"2003","journal-title":"Nucl Med Commun"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1001\/jama.299.19.jed80027","article-title":"The future of clinical trials evaluating blood substitutes","volume":"299","author":"DA Fergusson","year":"2008","journal-title":"JAMA"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0047559","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T20:34:37Z","timestamp":1562272477000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0047559"}},"subtitle":[],"editor":[{"given":"Antonio Paolo","family":"Beltrami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,10,25]]},"references-count":57,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2012,10,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0047559","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,25]]}}}